Literature DB >> 526399

A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.

A G Chalmers, J Hunter, C D Lees, J A Millar, J J Brown, J I Robertson.   

Abstract

1 The effects of labetalol, bethanidine and combined treatment with both drugs were compared in a within-patient randomized cross-over study in mild essential hypertension. Attention was directed to whether or not labetalol and bethanidine differed in their pattern of effect on arterial BP and whether evidence of synergism was apparent. 2 At the doses used labetalol significantly lowered systolic and diastolic BPs and heart rate lying, sitting, standing and after exercise. The dose of bethanidine used did not affect heart rate significantly while lowering systolic and diastolic BPs only after exercise and less clearly on standing. Combined treatment lowered BPs on standing and after exercise and heart rate after exercise. 3 The type and frequency of side-effects were similar with bethanidine and labetalol but were much less with combined treatment. 4 No evidence of synergism was observed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526399      PMCID: PMC1429747     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Therapeutic effects of beta-adrenoceptor blocking agents in hypertension.

Authors:  W H Birkenhäger; P W De Leeuw; A Wester; T L Kho; R Vandongen; H E Falke
Journal:  Ergeb Inn Med Kinderheilkd       Date:  1977

2.  Closing remarks: current status of labetalol.

Authors:  C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

3.  EFFECTS OF GUANETHIDINE, RESERPINE, AND METHYLDOPA ON REFLEX VENOUS AND ARTERIAL CONSTRICTION IN MAN.

Authors:  D T MASON; E BRAUNWALD
Journal:  J Clin Invest       Date:  1964-07       Impact factor: 14.808

4.  CONCERNING THE MODE OF ACTION OF GUANETHIDINE AND SOME DERIVATIVES IN AUGMENTING THE VASOMOTOR ACTION OF ADRENERGIC AMINES IN VASCULAR TISSUES OF THE RABBIT.

Authors:  R A MAXWELL
Journal:  J Pharmacol Exp Ther       Date:  1965-06       Impact factor: 4.030

5.  Supersensitivity of salivary glands following treatment with bretylium or guanethidine.

Authors:  N EMMELIN; J ENGSTROM
Journal:  Br J Pharmacol Chemother       Date:  1961-06

6.  Letter: Guanethidine in hypertension.

Authors:  W D Alexander
Journal:  Br Med J       Date:  1976-05-29

Review 7.  Labetalol: a review of its pharmacology and therapeutic use in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

8.  Guanethidine-resistant hypertension.

Authors:  G Sandler; A W Leishman; P M Humberstone
Journal:  Circulation       Date:  1968-09       Impact factor: 29.690

9.  Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.

Authors:  E A Rosei; J J Brown; A F Lever; A S Robertson; J I Robertson; P M Trust
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.